12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cara, Maruishi deal

Cara granted Maruishi exclusive rights in Japan to develop and commercialize CR845 for acute pain and uremic pruritus. Cara...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >